LESLIE GILLETTE: Open Payments
NPI 1063051449 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,192 in 133 payments from 17 companies in 2025. Trend: 2023 $1,012 · 2024 $1,238 · 2025 $2,192
Food & beverage: $2,192
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 31 | $330 |
| UCB, Inc. | 17 | $314 |
| Janssen Biotech, Inc. | 8 | $219 |
| Novartis Pharmaceuticals Corporation | 14 | $200 |
| PFIZER INC. | 9 | $194 |
| Galderma Laboratories, L.P. | 13 | $167 |
| Organon LLC | 12 | $129 |
| LEO Pharma Inc. | 6 | $128 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| GENZYME CORPORATION | 4 | $96 |
Products named: Zoryve, Bimzelx, TREMFYA, DUPIXENT, CIBINQO, NEMLUVIO, COSENTYX, SKYRIZI.
Industry payments across OK — which companies pay providers there.
